FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012024495> ?p ?o ?g. }

• W2012024495 endingPage "132" @default.
• W2012024495 startingPage "124" @default.
• W2012024495 abstract "ObjectiveLeukemia-initiating cells (LICs) have been the subject of considerable investigation because of their ability to self-renew and maintain leukemia. Thus, selective targeting and killing of LICs would provide highly efficient and novel therapeutic strategies. Here we explored whether we could use a canine leukemia cell line (G374) derived from a dog that received HOXB4-transduced repopulating cells to study leukemia in the murine xenograft model and the dog.Materials and MethodsG374 cells were infused in dogs intravenously and in nonobese diabetic/severe combined immunodeficient and nonobese diabetic/severe combined immunodeficient/IL2Rγnull mice either intravenously or directly into the bone cavity. Animals were bled to track engraftment and proliferation of G374 cells, and were sacrificed when they appeared ill.ResultsWe found that canine LICs are capable of sustained in vitro self-renewal while maintaining their ability to induce acute myeloid leukemia, which resembles human disease in both dogs and mice. Furthermore, we developed a novel strategy for the quantification of LIC frequency in large animals and showed that this frequency was highly comparable to that determined by limited dilution in mouse xenotransplants. We also demonstrated, using single-cell analysis, that LICs are heterogeneous in their self-renewal capacity and regenerate a leukemic cell population consistent with a hierarchical leukemia model.ConclusionsThe availability of this novel framework should accelerate the characterization of LICs and the translation of animal studies into clinical trials. Leukemia-initiating cells (LICs) have been the subject of considerable investigation because of their ability to self-renew and maintain leukemia. Thus, selective targeting and killing of LICs would provide highly efficient and novel therapeutic strategies. Here we explored whether we could use a canine leukemia cell line (G374) derived from a dog that received HOXB4-transduced repopulating cells to study leukemia in the murine xenograft model and the dog. G374 cells were infused in dogs intravenously and in nonobese diabetic/severe combined immunodeficient and nonobese diabetic/severe combined immunodeficient/IL2Rγnull mice either intravenously or directly into the bone cavity. Animals were bled to track engraftment and proliferation of G374 cells, and were sacrificed when they appeared ill. We found that canine LICs are capable of sustained in vitro self-renewal while maintaining their ability to induce acute myeloid leukemia, which resembles human disease in both dogs and mice. Furthermore, we developed a novel strategy for the quantification of LIC frequency in large animals and showed that this frequency was highly comparable to that determined by limited dilution in mouse xenotransplants. We also demonstrated, using single-cell analysis, that LICs are heterogeneous in their self-renewal capacity and regenerate a leukemic cell population consistent with a hierarchical leukemia model. The availability of this novel framework should accelerate the characterization of LICs and the translation of animal studies into clinical trials." @default.
• W2012024495 created "2016-06-24" @default.
• W2012024495 creator A5003279647 @default.
• W2012024495 creator A5024703985 @default.
• W2012024495 creator A5069750447 @default.
• W2012024495 creator A5076665794 @default.
• W2012024495 date "2011-01-01" @default.
• W2012024495 modified "2023-10-01" @default.
• W2012024495 title "Insights into leukemia-initiating cell frequency and self-renewal from a novel canine model of leukemia" @default.
• W2012024495 cites W1527650697 @default.
• W2012024495 cites W1968238001 @default.
• W2012024495 cites W1971722611 @default.
• W2012024495 cites W1975255631 @default.
• W2012024495 cites W1979421565 @default.
• W2012024495 cites W1983641075 @default.
• W2012024495 cites W1985760249 @default.
• W2012024495 cites W1988215341 @default.
• W2012024495 cites W1990779222 @default.
• W2012024495 cites W1999453504 @default.
• W2012024495 cites W2006351191 @default.
• W2012024495 cites W2009886857 @default.
• W2012024495 cites W2017598005 @default.
• W2012024495 cites W2024123171 @default.
• W2012024495 cites W2031991098 @default.
• W2012024495 cites W2033314804 @default.
• W2012024495 cites W2033548186 @default.
• W2012024495 cites W2040649840 @default.
• W2012024495 cites W2048385227 @default.
• W2012024495 cites W2060865120 @default.
• W2012024495 cites W2066858578 @default.
• W2012024495 cites W2084507055 @default.
• W2012024495 cites W2094383506 @default.
• W2012024495 cites W2094735859 @default.
• W2012024495 cites W2104666893 @default.
• W2012024495 cites W2107306736 @default.
• W2012024495 cites W2109336877 @default.
• W2012024495 cites W2118765054 @default.
• W2012024495 cites W2119749554 @default.
• W2012024495 cites W2123719503 @default.
• W2012024495 cites W2137906256 @default.
• W2012024495 cites W2145254159 @default.
• W2012024495 cites W3043125680 @default.
• W2012024495 doi "https://doi.org/10.1016/j.exphem.2010.09.012" @default.
• W2012024495 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3291513" @default.
• W2012024495 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20933571" @default.
• W2012024495 hasPublicationYear "2011" @default.
• W2012024495 type Work @default.
• W2012024495 sameAs 2012024495 @default.
• W2012024495 citedByCount "1" @default.
• W2012024495 countsByYear W20120244952015 @default.
• W2012024495 crossrefType "journal-article" @default.
• W2012024495 hasAuthorship W2012024495A5003279647 @default.
• W2012024495 hasAuthorship W2012024495A5024703985 @default.
• W2012024495 hasAuthorship W2012024495A5069750447 @default.
• W2012024495 hasAuthorship W2012024495A5076665794 @default.
• W2012024495 hasBestOaLocation W20120244951 @default.
• W2012024495 hasConcept C203014093 @default.
• W2012024495 hasConcept C2778461978 @default.
• W2012024495 hasConcept C2778729363 @default.
• W2012024495 hasConcept C2780007613 @default.
• W2012024495 hasConcept C28328180 @default.
• W2012024495 hasConcept C502942594 @default.
• W2012024495 hasConcept C71924100 @default.
• W2012024495 hasConcept C86803240 @default.
• W2012024495 hasConcept C95444343 @default.
• W2012024495 hasConceptScore W2012024495C203014093 @default.
• W2012024495 hasConceptScore W2012024495C2778461978 @default.
• W2012024495 hasConceptScore W2012024495C2778729363 @default.
• W2012024495 hasConceptScore W2012024495C2780007613 @default.
• W2012024495 hasConceptScore W2012024495C28328180 @default.
• W2012024495 hasConceptScore W2012024495C502942594 @default.
• W2012024495 hasConceptScore W2012024495C71924100 @default.
• W2012024495 hasConceptScore W2012024495C86803240 @default.
• W2012024495 hasConceptScore W2012024495C95444343 @default.
• W2012024495 hasIssue "1" @default.
• W2012024495 hasLocation W20120244951 @default.
• W2012024495 hasLocation W20120244952 @default.
• W2012024495 hasLocation W20120244953 @default.
• W2012024495 hasLocation W20120244954 @default.
• W2012024495 hasOpenAccess W2012024495 @default.
• W2012024495 hasPrimaryLocation W20120244951 @default.
• W2012024495 hasRelatedWork W1974032072 @default.
• W2012024495 hasRelatedWork W1975473919 @default.
• W2012024495 hasRelatedWork W2090016234 @default.
• W2012024495 hasRelatedWork W2102605856 @default.
• W2012024495 hasRelatedWork W2347812052 @default.
• W2012024495 hasRelatedWork W2909695583 @default.
• W2012024495 hasRelatedWork W3039046190 @default.
• W2012024495 hasRelatedWork W3207807551 @default.
• W2012024495 hasRelatedWork W4207022676 @default.
• W2012024495 hasRelatedWork W42711520 @default.
• W2012024495 hasVolume "39" @default.
• W2012024495 isParatext "false" @default.
• W2012024495 isRetracted "false" @default.
• W2012024495 magId "2012024495" @default.
• W2012024495 workType "article" @default.